相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Abstract GS6-07: EMBRACA: A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician's choice of therapy in patients with advanced breast cancer and a germlineBRCAmutation
J Litton et al.
CANCER RESEARCH (2018)
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)
Jonathan Welti et al.
CLINICAL CANCER RESEARCH (2018)
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
Jun Luo et al.
EUROPEAN UROLOGY (2018)
A phase Ib open-label, dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with abiraterone or enzalutamide in metastatic castrate-resistant prostate cancer.
Ulka N. Vaishampayan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study
Benjamin A. Teply et al.
LANCET ONCOLOGY (2018)
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia et al.
NATURE GENETICS (2018)
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Michael Seiler et al.
NATURE MEDICINE (2018)
SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition
Yinan Li et al.
EUROPEAN UROLOGY (2017)
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer
Howard I. Scher et al.
EUROPEAN UROLOGY (2017)
Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer
Christof Bernemann et al.
EUROPEAN UROLOGY (2017)
Novel splice-switching oligonucleotide promotes BRCA1 aberrant splicing and susceptibility to PARP inhibitor action
Lindsay D. Smith et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration- Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
Emmanuel S. Antonarakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
N. D. James et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Evolutionary Relationship between Alternative Splicing and Gene Duplication
Luis P. Iniguez et al.
FRONTIERS IN GENETICS (2017)
The evolutionary fate of the chloroplast and nuclear rps16 genes as revealed through the sequencing and comparative analyses of four novel legume chloroplast genomes from Lupinus
J. Keller et al.
DNA RESEARCH (2017)
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance
Manish Kohli et al.
CLINICAL CANCER RESEARCH (2017)
Preclinical development and clinical validation of a whole blood pharmacodynamic marker assay for the BET bromodomain inhibitor ZEN-3694 in metastatic castration-resistant prostate cancer (mCRPC) patients
Laura Tsujikawa et al.
CANCER RESEARCH (2017)
Circulating cytokine levels predictive of Grade≥3 radiation pneumonitis: Preliminary secondary analysis of a randomized controlled trial of definitive chemoradiation in locally advanced NSCLC
Matthew S. Ning et al.
CANCER RESEARCH (2017)
RNA mis-splicing in disease
Marina M. Scotti et al.
NATURE REVIEWS GENETICS (2016)
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin
Yifan Wang et al.
CANCER RESEARCH (2016)
Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer
Jonathan Welti et al.
EUROPEAN UROLOGY (2016)
Control of the heat stress-induced alternative splicing of a subset of genes by hnRNP K
Koichi Yamamoto et al.
GENES TO CELLS (2016)
Prostate Cancer, Version 1.2016 Featured Updates to the NCCN Guidelines
James L. Mohler et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer
Irfan A. Asangani et al.
MOLECULAR CANCER RESEARCH (2016)
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Androgen receptor variation affects prostate cancer progression and drug resistance
Edel McCrea et al.
PHARMACOLOGICAL RESEARCH (2016)
Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
E. S. Antonarakis et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
Christine Henzler et al.
NATURE COMMUNICATIONS (2016)
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2016)
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge et al.
NATURE REVIEWS CANCER (2016)
The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches
Elisabeth Daguenet et al.
EMBO REPORTS (2015)
Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer
Eleni Efstathiou et al.
EUROPEAN UROLOGY (2015)
NF-kappa B2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer
Nagalakshmi Nadiminty et al.
MOLECULAR CANCER THERAPEUTICS (2015)
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Y. -T. Hsu et al.
NATURE (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing
Shinsuke Araki et al.
PLOS ONE (2015)
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study
Michael T. Schweizer et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3′ Splice Site Selection in SF3B1-mutated Cancers
Christopher DeBoever et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Targeting heat shock proteins in metastatic castration-resistant prostate cancer
Arun A. Azad et al.
NATURE REVIEWS UROLOGY (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Chengfei Liu et al.
CLINICAL CANCER RESEARCH (2014)
Aggressive Variants of Castration-Resistant Prostate Cancer
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2014)
Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials
Chiara Zanetta et al.
CLINICAL THERAPEUTICS (2014)
A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
D. S. Hong et al.
INVESTIGATIONAL NEW DRUGS (2014)
Identification of a BRCA1-mRNA Splicing Complex Required for Efficient DNA Repair and Maintenance of Genomic Stability
Kienan I. Savage et al.
MOLECULAR CELL (2014)
Context-dependent control of alternative splicing by RNA-binding proteins
Xiang-Dong Fu et al.
NATURE REVIEWS GENETICS (2014)
A day in the life of the spliceosome
A. Gregory Matera et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mechanisms of the androgen receptor splicing in prostate cancer cells
L. L. Liu et al.
ONCOGENE (2014)
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
Yingming Li et al.
CANCER RESEARCH (2013)
Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors
Ferry A. L. M. Eskens et al.
CLINICAL CANCER RESEARCH (2013)
Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors
Eun Mi Je et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
J. William Harbour et al.
NATURE GENETICS (2013)
Alternative splicing: a pivotal step between eukaryotic transcription and translation
Alberto R. Kornblihtt et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
A complex network of factors with overlapping affinities represses splicing through intronic elements
Yang Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T. Karantanos et al.
ONCOGENE (2013)
KLF6 Loss of Function in Human Prostate Cancer Progression Is Implicated in Resistance to Androgen Deprivation
XiaoMei Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin et al.
NATURE (2012)
The spliceosome as a target of novel antitumour drugs
Sophie Bonnal et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Intronic splicing enhancers, cognate splicing factors and context-dependent regulation rules
Yang Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer
Pablo E. Vivas-Mejia et al.
CLINICAL CANCER RESEARCH (2011)
The RNA-binding protein Sam68 is a multifunctional player in human cancer
Pamela Bielli et al.
ENDOCRINE-RELATED CANCER (2011)
Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation
Joanna Y. Ip et al.
GENOME RESEARCH (2011)
A New Trick of an Old Molecule: Androgen Receptor Splice Variants Taking the Stage?!
Zhiyong Guo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak et al.
LANCET (2011)
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Karen A. Gelmon et al.
LANCET ONCOLOGY (2011)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
Emma Hornberg et al.
PLOS ONE (2011)
Ordered and Dynamic Assembly of Single Spliceosomes
Aaron A. Hoskins et al.
SCIENCE (2011)
Alternative Splicing of the Cyclin D1 Proto-Oncogene Is Regulated by the RNA-Binding Protein Sam68
Maria Paola Paronetto et al.
CANCER RESEARCH (2010)
GP369, an FGFR2-IIIb-Specific Antibody, Exhibits Potent Antitumor Activity against Human Cancers Driven by Activated FGFR2 Signaling
Ailin Bai et al.
CANCER RESEARCH (2010)
Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF
Ryohei Furumai et al.
CANCER SCIENCE (2010)
Expansion of the eukaryotic proteome by alternative splicing
Timothy W. Nilsen et al.
NATURE (2010)
Genotoxic stress causes the accumulation of the splicing regulator Sam68 in nuclear foci of transcriptionally active chromatin
Roberta Busa et al.
NUCLEIC ACIDS RESEARCH (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Small Molecule Inhibitors of Yeast Pre-mRNA Splicing
Kelly G. Aukema et al.
ACS CHEMICAL BIOLOGY (2009)
Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon array
Xingyi Hang et al.
BMC GENOMICS (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
An inducible change in Fox-1/A2BP1 splicing modulates the alternative splicing of downstream neuronal target exons
Ji-Ann Lee et al.
GENES & DEVELOPMENT (2009)
Coactivator selective regulation of androgen receptor activity
Irina U. Agoulnik et al.
STEROIDS (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation
Amber J. Willems et al.
CLINICAL CANCER RESEARCH (2008)
The Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA Splicing
Kristine O'Brien et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structural basis for the nuclear import of the human androgen receptor
Mark L. Cutress et al.
JOURNAL OF CELL SCIENCE (2008)
Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer
Jean-Pascal Machiels et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
Zefeng Wang et al.
RNA (2008)
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Yoshihiko Kotake et al.
NATURE CHEMICAL BIOLOGY (2007)
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Daisuke Kaida et al.
NATURE CHEMICAL BIOLOGY (2007)
The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells
R. Busa et al.
ONCOGENE (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Total syntheses, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analogue
Brian J. Albert et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia
El Cherif Ibrahim et al.
HUMAN MUTATION (2007)
An RNA map predicting Nova-dependent splicing regulation
Jernej Ule et al.
NATURE (2006)
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
Takeshi Fukuhara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Androgen receptor modifications in prostate cancer cells upon long-term androgen ablation and antiandrogen treatment
RB Marques et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread
G Narla et al.
CANCER RESEARCH (2005)
Structural basis of androgen receptor binding to selective androgen response elements
PL Shaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107 I.: Taxonomy, fermentation, isolation and screening
T Sakai et al.
JOURNAL OF ANTIBIOTICS (2004)
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107 III.: In vitro and In vivo antitumor activities
Y Mizui et al.
JOURNAL OF ANTIBIOTICS (2004)
The role of fibroblast growth factors and their receptors in prostate cancer
B Kwabi-Addo et al.
ENDOCRINE-RELATED CANCER (2004)
Manipulation of alternative splicing by a newly developed inhibitor of Clks
M Muraki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia
MP Cuajungco et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
GEX1 compounds, novel antitumor antibiotics related to herboxidiene, produced by Streptomyces sp -: 1.: Taxonomy, production, isolation, physicochemical properties and biological activities
Y Sakai et al.
JOURNAL OF ANTIBIOTICS (2002)
The current state of hormonal therapy for prostate cancer
BA Hellerstedt et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2002)
Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer
J Zhou et al.
LUNG CANCER (2001)
Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer
AR Black et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
分享论文
